Stock listing

TWSE:1795 Lotus Pharmaceutical Co., Ltd. (美時) 股價

Follow Lotus Pharmaceutical Co., Ltd. into a list and get an email when it puts out news.

Share price · TWSE:1795

$180.00 TWD 0.00 (0.0%)

Close on Oct 15, 2026

Lotus Pharmaceutical Co., Ltd. logo
Ticker
TWSE:1795
Asset type
Stock
Sector
Health care
Industry
Pharmaceuticals
Exchange
TWSE
Currency
TWD

What changed lately

Latest news

Lotus Pharmaceutical Announces Acquisition of a Specialty Pharmaceutical Product in South Korea, Expanding Portfolio in Urology and Infectious Disease Prevention

May 22, 2026

Lotus Reports October 2025 Revenue of NT$2,753 Million

Nov 11, 2025

Lotus Enters License and Supply Agreement with Adalvo for Semaglutide injection

Oct 6, 2025

Alvogen Announces Sale to Lotus, Creating a Leading International Specialized Generics Platform

Sep 23, 2025

Lotus Pharmaceutical reports August 2025 Revenue of NT$1,160 Million

Sep 11, 2025

Lotus reports July 2025 Revenue of NT$2,397 Million

Aug 12, 2025

Lotus reports June 2025 Revenue of NT$1,044 Million

Jul 11, 2025

Lotus Announces TFDA Approval for Adcirca for PAH Treatment

Feb 12, 2025

Lotus Announces the Closing of the Alphachymotrypsine Choay Acquisition, Ready to consolidate revenue from Q1 2025

Jan 8, 2025

Lotus Reported Unaudited November Revenues of NT$1,061 million, YTD Revenue Surpassing the Total Revenue for 2023

Dec 11, 2024

All Lotus Pharmaceutical Co., Ltd. news

Decks

Lotus Pharmaceutical Co., Ltd. on 6ix

Sector
Health care
Industry
Pharmaceuticals
News releases
2 in the last 12 months · 21 in all · newest May 22, 2026 · oldest 2022
Decks
2 decks · latest Aug 14, 2026

Log in to ask 6ix AI your own questions about Lotus Pharmaceutical Co., Ltd.